In contrast to the modest glucose reduction with liver FATP2 inhibition (7), global FATP2 deletion is associated with profoundly lower plasma glucose in genetic and inducible mouse models of type 2 diabetes (11). Here, SLC27A2 is linked to type 2 diabetes mellitus.